Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma

Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of drug metabolism and pharmacokinetics 1997-07, Vol.22 (3), p.207-209
Hauptverfasser: SCHÜCK, O, BOHDANECKA, M, SEDIVY, J, KRAJICKOVA, M, CHADIMOVA, M, MATOUSOVIC, K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 209
container_issue 3
container_start_page 207
container_title European journal of drug metabolism and pharmacokinetics
container_volume 22
creator SCHÜCK, O
BOHDANECKA, M
SEDIVY, J
KRAJICKOVA, M
CHADIMOVA, M
MATOUSOVIC, K
description Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors responsible for reduced CyA availability under these conditions have not yet been identified.
doi_str_mv 10.1007/BF03189808
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79392952</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79392952</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-8f1c313032d9d77f58ed61895c6d0d18a39b9ba4e404cf5f2c24f39071b7b05f3</originalsourceid><addsrcrecordid>eNpFkM1LxDAQxYMo67LuxbuQg3gQqpOkaZKjLq4KCx7Uc0nTxK32y6QF9783smWdy2Pm_Rh4D6FzAjcEQNzer4ERqSTIIzSnBEQCRMIxmgMTMhEqy07RMoRPiMOk4jyboZliXFKAOXpdbXX7YQOuWmx2pu5C3_mqtfgOf0UZKhOwdoP12P701leNbQddY2_L0QxV1-LOxaWNp15HNdtdo8_QidN1sMtJF-h9_fC2eko2L4_Pq7tNYqiAIZGOGEYYMFqqUgjHpS2zmISbrISSSM1UoQqd2hRS47ijhqaOKRCkEAVwxxboav-39933aMOQN1Uwtq51a7sx5EIxRRWnEbzeg8Z3IXjr8j4m0X6XE8j_Ssz_S4zwxfR1LBpbHtCpsuhfTr4ORtfO69ZU4YBRmSqZAfsFpUl4ew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79392952</pqid></control><display><type>article</type><title>Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>SCHÜCK, O ; BOHDANECKA, M ; SEDIVY, J ; KRAJICKOVA, M ; CHADIMOVA, M ; MATOUSOVIC, K</creator><creatorcontrib>SCHÜCK, O ; BOHDANECKA, M ; SEDIVY, J ; KRAJICKOVA, M ; CHADIMOVA, M ; MATOUSOVIC, K</creatorcontrib><description>Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors responsible for reduced CyA availability under these conditions have not yet been identified.</description><identifier>ISSN: 0378-7966</identifier><identifier>EISSN: 2107-0180</identifier><identifier>DOI: 10.1007/BF03189808</identifier><identifier>PMID: 9358200</identifier><language>eng</language><publisher>Genève: Médecine et hygiène</publisher><subject>Animals ; Biological and medical sciences ; Cyclosporine - blood ; Cyclosporine - pharmacokinetics ; Immunomodulators ; Immunosuppressive Agents - blood ; Immunosuppressive Agents - pharmacokinetics ; Kidney - metabolism ; Male ; Medical sciences ; Nephrectomy - methods ; Pharmacology. Drug treatments ; Rats ; Renal Insufficiency - metabolism ; Time Factors</subject><ispartof>European journal of drug metabolism and pharmacokinetics, 1997-07, Vol.22 (3), p.207-209</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-8f1c313032d9d77f58ed61895c6d0d18a39b9ba4e404cf5f2c24f39071b7b05f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2849860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9358200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHÜCK, O</creatorcontrib><creatorcontrib>BOHDANECKA, M</creatorcontrib><creatorcontrib>SEDIVY, J</creatorcontrib><creatorcontrib>KRAJICKOVA, M</creatorcontrib><creatorcontrib>CHADIMOVA, M</creatorcontrib><creatorcontrib>MATOUSOVIC, K</creatorcontrib><title>Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma</title><title>European journal of drug metabolism and pharmacokinetics</title><addtitle>Eur J Drug Metab Pharmacokinet</addtitle><description>Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors responsible for reduced CyA availability under these conditions have not yet been identified.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cyclosporine - blood</subject><subject>Cyclosporine - pharmacokinetics</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - blood</subject><subject>Immunosuppressive Agents - pharmacokinetics</subject><subject>Kidney - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrectomy - methods</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Renal Insufficiency - metabolism</subject><subject>Time Factors</subject><issn>0378-7966</issn><issn>2107-0180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1LxDAQxYMo67LuxbuQg3gQqpOkaZKjLq4KCx7Uc0nTxK32y6QF9783smWdy2Pm_Rh4D6FzAjcEQNzer4ERqSTIIzSnBEQCRMIxmgMTMhEqy07RMoRPiMOk4jyboZliXFKAOXpdbXX7YQOuWmx2pu5C3_mqtfgOf0UZKhOwdoP12P701leNbQddY2_L0QxV1-LOxaWNp15HNdtdo8_QidN1sMtJF-h9_fC2eko2L4_Pq7tNYqiAIZGOGEYYMFqqUgjHpS2zmISbrISSSM1UoQqd2hRS47ijhqaOKRCkEAVwxxboav-39933aMOQN1Uwtq51a7sx5EIxRRWnEbzeg8Z3IXjr8j4m0X6XE8j_Ssz_S4zwxfR1LBpbHtCpsuhfTr4ORtfO69ZU4YBRmSqZAfsFpUl4ew</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>SCHÜCK, O</creator><creator>BOHDANECKA, M</creator><creator>SEDIVY, J</creator><creator>KRAJICKOVA, M</creator><creator>CHADIMOVA, M</creator><creator>MATOUSOVIC, K</creator><general>Médecine et hygiène</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma</title><author>SCHÜCK, O ; BOHDANECKA, M ; SEDIVY, J ; KRAJICKOVA, M ; CHADIMOVA, M ; MATOUSOVIC, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-8f1c313032d9d77f58ed61895c6d0d18a39b9ba4e404cf5f2c24f39071b7b05f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cyclosporine - blood</topic><topic>Cyclosporine - pharmacokinetics</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - blood</topic><topic>Immunosuppressive Agents - pharmacokinetics</topic><topic>Kidney - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrectomy - methods</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Renal Insufficiency - metabolism</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHÜCK, O</creatorcontrib><creatorcontrib>BOHDANECKA, M</creatorcontrib><creatorcontrib>SEDIVY, J</creatorcontrib><creatorcontrib>KRAJICKOVA, M</creatorcontrib><creatorcontrib>CHADIMOVA, M</creatorcontrib><creatorcontrib>MATOUSOVIC, K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of drug metabolism and pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHÜCK, O</au><au>BOHDANECKA, M</au><au>SEDIVY, J</au><au>KRAJICKOVA, M</au><au>CHADIMOVA, M</au><au>MATOUSOVIC, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma</atitle><jtitle>European journal of drug metabolism and pharmacokinetics</jtitle><addtitle>Eur J Drug Metab Pharmacokinet</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>22</volume><issue>3</issue><spage>207</spage><epage>209</epage><pages>207-209</pages><issn>0378-7966</issn><eissn>2107-0180</eissn><abstract>Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors responsible for reduced CyA availability under these conditions have not yet been identified.</abstract><cop>Genève</cop><pub>Médecine et hygiène</pub><pmid>9358200</pmid><doi>10.1007/BF03189808</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-7966
ispartof European journal of drug metabolism and pharmacokinetics, 1997-07, Vol.22 (3), p.207-209
issn 0378-7966
2107-0180
language eng
recordid cdi_proquest_miscellaneous_79392952
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Animals
Biological and medical sciences
Cyclosporine - blood
Cyclosporine - pharmacokinetics
Immunomodulators
Immunosuppressive Agents - blood
Immunosuppressive Agents - pharmacokinetics
Kidney - metabolism
Male
Medical sciences
Nephrectomy - methods
Pharmacology. Drug treatments
Rats
Renal Insufficiency - metabolism
Time Factors
title Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T01%3A21%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20cyclosporine%20A%20kinetics%20after%20experimental%20reduction%20of%20renal%20parenchyma&rft.jtitle=European%20journal%20of%20drug%20metabolism%20and%20pharmacokinetics&rft.au=SCH%C3%9CCK,%20O&rft.date=1997-07-01&rft.volume=22&rft.issue=3&rft.spage=207&rft.epage=209&rft.pages=207-209&rft.issn=0378-7966&rft.eissn=2107-0180&rft_id=info:doi/10.1007/BF03189808&rft_dat=%3Cproquest_cross%3E79392952%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79392952&rft_id=info:pmid/9358200&rfr_iscdi=true